Have anxiety disorders been disowned by psychiatrists?

REFERENCES

• Baldwin DS, Allgulander C, Altamura AC . Manifesto for a European Anxiety Disorders Research Network. European Neuropsychopharmacology 2010; 20: 426–432.
   PubMed Web of Science ®Google Scholar
• Sareen J, Cox BJ, Afifi TO . Anxiety disorders and risk for suicidal ideation and suicide attempts: a population-based longitudinal study of adults. Archives of General Psychiatry 2005; 62: 1249–1257.
   PubMed Web of Science ®Google Scholar
• Bolton JM, Cox BJ, Afifi TO, Enns MW, Bienvenu JF, Sareen J. Anxiety disorders and risk for suicide attempts: findings from the Baltimore Epidemiologic Catchment Area Follow-up Study. Depression and Anxiety 2008; 25: 477–481.
   PubMed Web of Science ®Google Scholar
• Hawgood J, De Leo D. Anxiety disorders and suicidal behaviour: an update. Current Opinion in Psychiatry 2008; 21: 51–64.
   PubMed Web of Science ®Google Scholar
• Allgulander C, Lavori PW. Excess mortality among 3302 patients with “pure” anxiety neurosis. Archives of General Psychiatry 1991; 48: 599–602.
   PubMed Web of Science ®Google Scholar
• Kawachi I, Colditz GA, Ascherio A . Coronary heart disease/myocardial infacrtion: prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation 1994; 89: 1992–1997.
   PubMed Web of Science ®Google Scholar
• Smoller JW, Pollack MH, Wassertheil-Smoller S . Panic attacks and risk of incident cardiovascular events among postmenopausal women in the Women's Health Initiative Observational Study. Archives of General Psychiatry 2007; 64: 1153–1160.
   PubMed Web of Science ®Google Scholar
• Janszky I, Ahnve S, Lundberg I, Hemmingsson T. Early-onset depression, anxiety, and risk of subsequent coronary heart disease: 37-year follow-up of 49,321 young Swedish men. Journal of the American College of Cardiology 2010; 56: 31–37.
   PubMed Web of Science ®Google Scholar
• Roest AM, Martens EJ, de Jonge P, Denollet J. Anxiety and risk of incident coronary heart disease: a meta-analysis. Journal of the American College of Cardiology 2010; 56: 38–46.
   PubMed Web of Science ®Google Scholar
• Wittchen H-U, Beesdo K, Bittner A, Goodwin RD. Depressive episodes – evidence for a causal role of primary anxiety disorders? European Psychiatry 2003; 18: 384–393.
   PubMed Web of Science ®Google Scholar
• Beesdo K, Bittner A, Pine DS . Incidence of social anxiety disorder and the consistent risk for secondary depression in the first three decades of life. Archives of General Psychiatry 2007; 64: 903–912.
   PubMed Web of Science ®Google Scholar
• Buckner JD, Schmidt NB, Lang AR, Small JW, Schlauch RC, Lewinsohn PM. Specificity of social anxiety disorder as a risk factor for alcohol and cannabis dependence. Journal of Psychiatric Research 2008; 42: 230–239.
   PubMed Web of Science ®Google Scholar
• Srole L, Langner TS, Michael ST, Opler MK, Rennie TAC. Mental Health in the Metropolis: The Midtown Manhattan Study. New York: McGraw-Hill, 1962.
   Google Scholar
• Herzberg D. Happy Pills in America: From Miltown to Prozac. Baltimore: Johns Hopkins University Press, 2009.
   Google Scholar
• Farber LH. Merchandising depression. Psychology Today 1979; 12 (April): 63–64.
   Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd (DSM-III). Washington, DC: American Psychiatric Association, 1980.
   Google Scholar
• Salzman C. The APA Task Force report on benzodiazepine dependence, toxicity, and abuse. American Journal of Psychiatry 1991; 148: 151–152.
   PubMed Web of Science ®Google Scholar
• Tyrer P. Anxiety: A Multidisciplinary Review. Singapore: World Scientific Publishing Company, 1999.
   Google Scholar
• Healy D. The Creation of Psychopharmacology. Cambridge, MA: Harvard University Press, 2002.
   Google Scholar
• Bruce SE, Vasile RG, Goisman RM . Are benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia? American Journal of Psychiatry 2003; 160: 1432–1438.
   PubMed Web of Science ®Google Scholar
• Vasile RG, Bruce SE, Goisman RM, Pagano M, Keller MB. Results of a naturalistic longitudinal study of benzodiazepine and SSRI use in the treatment of generalized anxiety disorder and social phobia. Depression and Anxiety 2005; 22: 59–67.
   PubMed Web of Science ®Google Scholar
• Tone A. Listening to the past: history, psychiatry, and anxiety. Canadian Journal of Psychiatry 2005; 50: 373–380. (Rickels K. Interview with David Healy, 1998. Located at: International Neuropsychopharmacology Archives, Vanderbilt University, Nashville, TN, USA)
   PubMed Web of Science ®Google Scholar
• Worthington JJ, Pollack MH, Otto MW, McLean RYS, Moroz G, Rosenbaum JF. Long-term experience with clonazepam in patients with a primary diagnosis of panic disorder. Psychopharmacology Bulletin 1998; 34: 199–205.
   PubMedGoogle Scholar
• Soumerai SB, Simoni-Wastila L, Singer C . Lack of relationship between long-term use of benzodiazepines and escalation to high dosages. Psychiatric Services 2003; 54: 1006–1011.
   PubMed Web of Science ®Google Scholar
• Mol AJJ, Gorgels WJMJ, Voshaar RCO . Associations of benzodiazepine craving with other clinical variables in a population of general practice patients. Comprehensive Psychiatry 2005; 46: 353–360.
   PubMed Web of Science ®Google Scholar
• Rosenbaum JF. Attitudes toward benzodiazepines over the years. Journal of Clinical Psychiatry 2005; 66 (Suppl 2): 4–8.
   PubMedGoogle Scholar
• Busto UE, Bremner KE, Knight K, terBrugge K, Sellers EM. Long-term benzodiazepine therapy does not result in brain abnormalities. Journal of Clinical Psychopharmacology 2000; 20: 2–6.
   PubMed Web of Science ®Google Scholar
• World Health Organization. The ICD-10 (International Classification of Diseases) Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization, 1992.
   Google Scholar
• Holmes J. All you need is cognitive behaviour therapy? BMJ 2002; 324: 288–290.
   PubMed Web of Science ®Google Scholar
• Abramowitz JS. Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: a quantitative review. Journal of Consulting and Clinical Psychology 1997; 65: 44–52.
   PubMed Web of Science ®Google Scholar
• Davidson JR, Foa EB, Huppert JD . Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia. Archives of General Psychiatry 2004; 61: 1005–1013.
   PubMed Web of Science ®Google Scholar
• Mitte K. Meta-analysis of cognitive-behavioral treatments for generalized anxiety disorder: a comparison with pharmacotherapy. Psychological Bulletin 2005; 131: 785–795.
   PubMed Web of Science ®Google Scholar
• Bandelow B, Seidler-Brandler U, Becker A, Wedekind D, Rüther E. Meta-analysis of randomized controlled comparisons of psychopharmacological and psychological treatments for anxiety disorders. World Journal of Biological Psychiatry 2007; 8: 175–187.
   PubMed Web of Science ®Google Scholar
• Marks IM, Swinson RP, Basoglu M . Alprazolam and exposure alone and combined in panic disorder with agoraphobia: a controlled study in London and Toronto. British Journal of Psychiatry 1993; 162: 776–787.
   PubMed Web of Science ®Google Scholar
• Liebowitz MR, Heimberg RG, Schneier FR . Cognitive-behavioral group therapy versus phenelzine in social phobia: long-term outcome. Depression and Anxiety 1999; 10: 89–98.
   PubMed Web of Science ®Google Scholar
• Simpson HB, Liebowitz MR, Foa EB . Post-treatment effects of exposure therapy and clomipramine in obsessive-compulsive disorder. Depression and Anxiety 2004; 19: 225–233.
   PubMed Web of Science ®Google Scholar
• Loerch B, Graf-Morgenstern M, Hautzinger M . Randomised placebo-controlled trial of moclobemide, cognitive-behavioural therapy and their combination in panic disorder with agoraphobia. British Journal of Psychiatry 1999; 174: 205–212.
   PubMed Web of Science ®Google Scholar
• Nadiga DN, Hensley PL, Uhlenhuth EH. Review of the long-term effectiveness of cognitive behavioral therapy compared to medications in panic disorder. Depression and Anxiety 2003; 17: 58–64.
   PubMed Web of Science ®Google Scholar
• Katschnig H. Are psychiatrists an endangered species? Observations on internal and external challenges to the profession. World Psychiatry 2010; 9: 21–28.
   PubMed Web of Science ®Google Scholar